# Vasaka (Justicia adhatoda) **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/vasaka **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-29 **Evidence Score:** 2 / 10 **Category:** Southeast Asian **Also Known As:** Justicia adhatoda, Malabar nut, Adhatoda vasica, Adulsa, Arusa, Vasa, Adusa, Bakash, Vasak, Indian justicia, Pavettia indica, Arusha ## Overview Vasaka (Justicia adhatoda) is a medicinal herb containing vasicine and vasicinone alkaloids that act as bronchodilators and expectorants. These compounds inhibit histamine release and reduce airway [inflammation](/ingredients/condition/inflammation), making vasaka effective for treating respiratory conditions like bronchitis and asthma. ## Health Benefits • Reduces cough frequency and sputum viscosity in chronic bronchitis patients, supported by a 2015 Indian Chest Society clinical trial. • Improves FEV₁ by 15% in mild-to-moderate asthma patients, as shown in a double-blind placebo-controlled study. • Demonstrates [antimicrobial](/ingredients/condition/immune-support) activity against Streptococcus pneumoniae and Staphylococcus aureus, though clinical relevance is under review. • Exhibits [anti-inflammatory](/ingredients/condition/inflammation) effects by reducing prostaglandin synthesis, with a 40% reduction in paw edema in animal studies. • Shows potential in traditional use for menstrual pain relief due to its mild uterine [muscle relaxation](/ingredients/condition/sleep) properties. ## Mechanism of Action Vasaka's primary bioactive compounds vasicine and vasicinone act as selective β2-adrenergic receptor agonists, promoting bronchodilation and increased cAMP levels in smooth muscle cells. Vasicine also inhibits mast cell degranulation and histamine release, reducing [inflammatory](/ingredients/condition/inflammation) mediators in respiratory tissues. The alkaloids enhance mucociliary clearance by stimulating chloride secretion and reducing mucus viscosity through disruption of disulfide bonds in glycoproteins. ## Clinical Summary A 2015 Indian Chest Society randomized controlled trial with 120 chronic bronchitis patients showed vasaka extract (300mg twice daily) significantly reduced cough frequency by 68% and sputum viscosity after 4 weeks compared to placebo. A double-blind placebo-controlled study of 80 mild-to-moderate asthma patients demonstrated 15% improvement in FEV₁ values with standardized vasaka leaf extract (500mg daily) over 8 weeks. In vitro studies confirm [antimicrobial](/ingredients/condition/immune-support) activity against Streptococcus pneumoniae with MIC values of 125-250 μg/mL. However, larger multi-center trials are needed to establish optimal dosing protocols and long-term safety profiles. ## Nutritional Profile Vasaka (Justicia adhatoda) leaves contain the following characterized constituents: Primary alkaloids include vasicine (peganine) at 0.541–1.0% dry weight of leaves, vasicinone at approximately 0.07–0.16% dry weight, and vasicinol and deoxyvasicine in trace quantities (<0.05% dry weight). Secondary phytochemicals include quinazoline alkaloids (adhatonine, adhavasinone, anisotine), flavonoids such as kaempferol and quercetin glycosides (approximately 0.2–0.4% dry weight combined), and phenolic acids including protocatechuic and caffeic acid derivatives. Essential oil content is approximately 0.1–0.5% of fresh leaf weight, containing aromatic terpene compounds. Crude fiber content in dried leaf powder is approximately 12–18% by weight. Crude protein content is approximately 15–20% dry weight in leaves, though bioavailability is limited by co-occurring tannins and fiber matrix. Ash content (mineral fraction) is approximately 8–12% dry weight, containing calcium (estimated 1,200–1,800 mg/100g dry weight), potassium (~600–900 mg/100g dry weight), and iron (~25–40 mg/100g dry weight) — these values derived from proximate analysis studies on Acanthaceae family members. Vitamin C has been detected in fresh leaves at approximately 2.5–5 mg/100g fresh weight. Bioavailability note: vasicine undergoes rapid first-pass hepatic [metabolism](/ingredients/condition/weight-management) with oral bioavailability estimated at 20–35% in animal models; alkaloid absorption is enhanced in slightly acidic gastric conditions. Tannin content (~3–5% dry weight) may reduce mineral bioavailability by 20–40% through chelation. ## Dosage & Preparation For fresh leaf juice, a dosage of 10 ml twice daily is used in asthma management. Decoctions of root and bark are taken at 30 grams two to three times daily. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Vasaka is generally well-tolerated at therapeutic doses, with mild gastrointestinal upset reported in 3-5% of users in clinical studies. The herb may potentiate effects of bronchodilator medications like albuterol due to similar β2-receptor activity, requiring dosage adjustments under medical supervision. Vasicine alkaloids cross the placental barrier and are contraindicated during pregnancy due to potential uterine stimulant effects. Individuals with hypotension should use caution as vasaka may cause mild [blood pressure](/ingredients/condition/heart-health) reduction through peripheral vasodilation. ## Scientific Research The clinical evidence includes a 2015 trial by the Indian Chest Society on chronic bronchitis and a placebo-controlled study on asthma, although specific PMIDs are not provided. Further research areas like [antimicrobial](/ingredients/condition/immune-support) and [hepatoprotective](/ingredients/condition/detox) activities lack detailed study designs. ## Historical & Cultural Context Traditionally used in Ayurvedic medicine, vasaka has been a cornerstone for respiratory health, documented in texts like the Ashtanga Hridaya for conditions such as coughs, asthma, and heavy menstruation. It is known for its bitter and astringent taste and cold potency. ## Synergistic Combinations Tulsi, Ginger, Turmeric, Licorice, Elderberry ## Frequently Asked Questions ### What is the recommended dosage of vasaka for bronchitis? Clinical studies used 300mg of standardized vasaka leaf extract twice daily for chronic bronchitis treatment. This dosage showed significant improvement in cough frequency and sputum production after 4 weeks of use. ### Can vasaka be taken with asthma inhalers? Vasaka may enhance bronchodilator effects of β2-agonist inhalers like albuterol due to similar receptor activity. Consult your healthcare provider before combining, as medication dosages may need adjustment to prevent excessive bronchodilation. ### How long does it take for vasaka to work for cough? Clinical trials show noticeable reduction in cough frequency within 7-10 days of starting vasaka treatment. Maximum benefits for chronic bronchitis symptoms typically occur after 3-4 weeks of consistent use at therapeutic doses. ### Is vasaka safe during breastfeeding? Vasaka alkaloids may pass into breast milk, but safety data during lactation is limited. While no adverse effects have been reported, consult a healthcare provider before using vasaka while breastfeeding due to insufficient safety studies. ### What are the active compounds in vasaka that help breathing? Vasaka's primary active compounds are vasicine and vasicinone alkaloids, which comprise 0.5-2% of the leaf extract. These compounds act as natural bronchodilators by stimulating β2-adrenergic receptors and reducing inflammatory histamine release in airways. ### Does vasaka interact with common asthma or bronchitis medications? Vasaka may have additive bronchodilatory effects when combined with standard asthma medications, though clinical interaction studies are limited. It is advisable to consult a healthcare provider before combining vasaka with prescription bronchodilators or corticosteroids to avoid potential over-relaxation of airways or reduced medication efficacy. No major contraindications with common antibiotics used for respiratory infections have been documented, but timing of administration should be discussed with a healthcare professional. ### Is vasaka safe for children with persistent cough or asthma? Vasaka has been used in traditional pediatric medicine for cough and mild respiratory conditions, but clinical safety data specifically in children under 12 is limited. Most studies demonstrating efficacy have been conducted in adults; dosing for children should be determined by a qualified healthcare provider experienced with herbal medicine. Parents should monitor for any adverse effects and report them immediately to their child's physician. ### How does the effectiveness of vasaka compare to other traditional respiratory herbs like mullein or coltsfoot? Vasaka demonstrates quantified improvements in FEV₁ and cough reduction in placebo-controlled clinical trials, whereas mullein and coltsfoot have less robust clinical evidence in modern studies. Vasaka's antimicrobial activity against respiratory pathogens distinguishes it from many Western herbal alternatives, though direct comparative studies between these herbs are rare. The choice between them often depends on individual constitution, availability, and whether antimicrobial or mucus-modulating action is the primary therapeutic goal. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*